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 Results from Mystery Client surveys demonstrate the need for written procedures and harmonization of practices for all collaborators, as more than a third of the responses differed in date/time and operator in a 
global view. 
 In the Presential Audit surveys we highlight as critical points the results regarding questions 3, 5 and 6, as they point to specific problems that occurred during the blood collection procedure, such as operator and
patient safety, as well as the quality of the sample collected, suggesting the need to review legal and normative issues and to train collaborators.
 Participants who use systematically these two methodologies are monitoring some of the requirements of ISO 15189:2012, namely 4.1.2.6, 4.3, 4.4.1, 4.14, 5.4.2 (both), 5.4.4.2 (mystery client) and 5.1.2, 5.2.2, 5.2.5, 
5.3.2.5, 5.3.2.7, 5.4.4 (presential audit), contributing to release reliable results for medical decisions.
 For the future, we will extend the questions and items in evaluation in these two surveys to Microbiology area and continuing to offer training in Preanalytical matters.
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Graphic 1 represents the results obtained from Mystery Client surveys distributed in 2015, 2017 and
2018. The 2019 survey will be conducted in the 4th quarter. The annual participation rate was 75% in
2015, 95% in 2017 and 63% in 2018.
Graphic 2 – Percentage (annual average) of the results obtained in accordance with good practice (see References) in 
the presential audits surveys carried out in 2016, 2017, 2018 and 2019, respectively. Notes: Question 2 was introduced 
in 2017; questions 3, 4, 12 and 13 were introduced in 2019; question 14 was reworded in 2019.
Graphic 1 – Distribution of results obtained in Mystery Client surveys performed in 2015, 2017 and 2018. Note:  bars 
with no data means that the item was not included in the “interview”. 
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Methodology
Mystery client was firstly performed in 2015. PNAEQ prepares an "interview" guide with questions
simulating a patient and makes two anonymous phone calls in different date/time to each laboratory.
Figure 1 presents the example performed in 2018 (the 2019 round will be performed in the 4th quarter).
The questions are regularly modified so that the participants cannot identify PNAEQ as the client. It is
also requested the name of the collaborator replying the phone in order to ascertain whether the two
telephone calls are answered by the same operator. Participants who do not answer after three attempts
are excluded of the round. Results are presented as a comparison of the answers obtained in the two
calls for the validated participants.
Methodology
The first checklist for presential audits
was launched in 2016. The checklist
(Figure 2) was updated four times based
on observed difficulties and incomplete
or inconsistent results obtained. The
audits are performed in two rounds
(except in 2018, only with one round) by
a laboratory collaborator with
competence and training in these
matters. In each round, the auditor
should attend to the collection of five
blood samples by eight technicians
(when possible). Audits should be
performed within no more than two
weeks to ensure that there are no
changes to the procedures. The audits
should be performed in two different
sites: blood collection sites/outpatient
consultation depending on it is a private
or public laboratory and in central
laboratory. Some questions about the
technician basic education, career time,
length of service and place of work are
also requested. Between the two
rounds, participants should provide
education to the technicians in order to
improve critical points.
Blood sampling
1st blood 
collection
2nd blood 
collection
3rd blood 
collection
4th blood 
collection
5th blood 
collection
1-Patient’s identification confirmed? 
(positive ID)
Yes    No Yes    No Yes    No Yes    No Yes    No
2-Patient properly prepared for blood 
sampling?
Yes    No Yes    No Yes    No Yes    No Yes    No
3-Use of gloves and sanitized hands by 
technician?
Yes    No Yes    No Yes    No Yes    No Yes    No
4-Venipuncture site cleaned properly? Yes    No Yes    No Yes    No Yes    No Yes    No
5-Blood collection system used?
oOpen system        
oClosed system
oOpen system        
oClosed system
oOpen system        
oClosed system
oOpen system        
oClosed system
oOpen system        
oClosed system
6-Used needle with safety system 
included?
Yes    No Yes    No Yes    No Yes    No Yes    No
7-Order of draw? (indicate 1st - 6th) (indicate 1st - 6th) (indicate 1st - 6th) (indicate 1st - 6th) (indicate 1st - 6th)
Blood culture bottle _____ _____ _____ _____ _____
Citrate tube _____ _____ _____ _____ _____
Plain tube or tube with clot activator _____ _____ _____ _____ _____
Heparin tube _____ _____ _____ _____ _____
EDTA tube _____ _____ _____ _____ _____
Glycolysis inhibitor tube _____ _____ _____ _____ _____
8-Tubes gently inverted after collection?
Blood culture bottle Yes    No Yes    No Yes    No Yes    No Yes    No
Citrate tube Yes    No Yes    No Yes    No Yes    No Yes    No
Plain tube or tube with clot activator Yes    No Yes    No Yes    No Yes    No Yes    No
Heparin tube Yes    No Yes    No Yes    No Yes    No Yes    No
EDTA tube Yes    No Yes    No Yes    No Yes    No Yes    No
Glycolysis inhibitor tube Yes    No Yes    No Yes    No Yes    No Yes    No
9-Ratio additive-blood respected?
Blood culture bottle Yes    No Yes    No Yes    No Yes    No Yes    No
Citrate tube Yes    No Yes    No Yes    No Yes    No Yes    No
Plain tube or tube with clot activator Yes    No Yes    No Yes    No Yes    No Yes    No
Heparin tube Yes    No Yes    No Yes    No Yes    No Yes    No
EDTA tube Yes    No Yes    No Yes    No Yes    No Yes    No
Glycolysis inhibitor tube Yes    No Yes    No Yes    No Yes    No Yes    No
10-How long the tourniquet was placed? _____ seconds _____ seconds _____ seconds _____ seconds _____ seconds
11-Tubes identified in the presence of the 
patient?
Yes    No Yes    No Yes    No Yes    No Yes    No
12-Collection time recorded? Yes    No Yes    No Yes    No Yes    No Yes    No
13-Blood collection supplies correctly 
disposed?
Yes    No Yes    No Yes    No Yes    No Yes    No
Notes (ex.: difficult venous blood access, 
etc.)
International literature describes the preanalytical phase as the most susceptible to errors due to the numerous non-automated activities it involves. Most EQA organizers offer preanalytical schemes to participants.
There are basically three types of surveys: procedures registration, samples circulation and errors registration. The Portuguese EQA Programme (PNAEQ) provides these type of schemes for 13 years, using as a guide
the ISO 15189:2012. In order to improve the evaluation of the preanalytical phase, PNAEQ recently launched two other preanalytical EQA schemes, mystery client and presential audits in 2015 and 2016, respectively.
The aim of the mystery client survey is to verify whether the information provided to the patient is constant regardless the day and time or if it is dependent on the collaborator.
The aim of the presential audit survey is to give the participants a tool to verify if the procedures performed daily are in accordance with laboratorial good practices recommendations
Figure 1 – Example of the "interview" guide performed in the 2018 round. 
Figure 2 – Checklist used for the blood collection presential audit, distributed 
in 2019 1st round.
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1-Patient’s identification confirmed
2-Patient properly prepared for
blood sampling
3-Use of gloves and sanitized hands
by technician
4-Venipuncture site cleaned
properly
5-Blood collection system used
6-Used needle with safety system
included
7-Order of draw
8-Tubes gently inverted after
collection
9-Ratio additive-blood respected
10-Tourniquet placed <60 sec
11-Tubes identified in the presence
of the patient
12-Collection time recorded
13-Blood collection supplies
correctly disposed
14-Safety standards complied
The results obtained over time in the presential audits surveys are shown in Graphic 2. In four years were
performed 1617 presential audits in 11 laboratories (annual average). Of the 52 collaborators audited
per year (annual average), most of them were biochemical technicians (79%) working in the central
laboratory (71%) for 6 or more years (56%) and with a career time equal or superior than 11 years (57%).
The annual participation rate was 53% in 2016, 70% in 2017, 60% in 2018 and 67% in 2019.
Good morning/ 
afternoon!
My parents have 
requests from our 
GP to do some 
clinical tests.
I would like to know 
what is required for 
the sample 
collection.
For my mother: vanillmandelic
acid, blood count, ESR, urea, 
creatinine, total cholesterol, 
triglycerides.
...
For my father: Total 
and Free PSA and 
Aseptic Urine.
Is it possible to email me 
this information? Or is the 
information available on 
your website?
And what is the time 
schedule of laboratory 
for blood collection?
Is it possible to pre scheduling 
the blood collection?
I am talking 
with?
......
...
... ...
Thank 
you!
